Dr. Steven Messe served as one of lead investigators for a randomized trial testing the usefulness of embolic protection devices to reduce stroke in aortic valve replacement.  Read the publication in JAMA:

Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial.

 

 

 

Glenn Konsky, DO

Glenn attended medical school at New York College of Osteopathic Medicine, and completed his residency in neurology at the University of Maryland.

 

 

Chris Renner, MD

Chris attended medical school at Drexel University, and completed his residency in neurology at Rutgers University-Robert Wood Johnson Medical School.

 

 

 

James Siegler, MD

Jim attended medical school at Tulane University, and completed his residency in neurology here at the University of Pennsylvania.

At the European Organization Stroke Conference on May 16, 2017, Dr. Scott Kasner, co-PI of the REDUCE trial, presented the results of the study.

Click below to watch a video interview reviewing the trial findings.